Evidence map›Paper›PMID 30039187›Full record

ArticleMetabolic brain disease2018

Influence of hippocampal GABA

Azam Almasi, Mohammad Zarei, Safoura Raoufi, Abdolrahman Sarihi, Iraj Salehi, Alireza Komaki, Nasrin Hashemi-Firouzi, Siamak Shahidi

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Monocolonization withMicrobiology spectrum · 2026
    Article
  2. Article
  3. Review
  4. Regulation of Hippocamposeptal Synaptic Transmission by GABAJournal of molecular neuroscience : MN · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. GABACurrent topics in behavioral neurosciences · 2022
    Review
  10. Article
  11. Density of GABAInternational journal of molecular sciences · 2020
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Azam AlmasiNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Mohammad ZareiNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Safoura RaoufiNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Abdolrahman SarihiNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Iraj SalehiNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Alireza KomakiNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Nasrin Hashemi-FirouziNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Siamak ShahidiNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. siamakshahidi@yahoo.com.ORCID http://orcid.org/0000-0001-8196-5223

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurotransmitter γ-aminobutyric acid (GABA) is involved in the process of memory. It has been reported that the inhibition of GABA

Indexed as

Amyloid beta-PeptidesAnimalsGABA AntagonistsHippocampusInjections, IntraventricularMaleMemoryMemory DisordersOrganophosphorus CompoundsRatsRats, WistarReceptors, GABA-BAmyloid beta-PeptidesCGP 35348GABA AntagonistsOrganophosphorus CompoundsReceptors, GABA-BAlzheimer diseaseDentate gyrusGABARecognitionβ-Amyloid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.